Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Seeking Alpha

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrAmplify Bloomberg U.S. Treasury 12% Premium Income ETF declares $90.227 dividend
FrAmplify CWP Growth & Income ETF declares $0.2269 dividend
FrSonim Technologies confirms receipt of unsolicited, non-binding proposal from Orbic North America
FrNike turnaround gains traction but hurdles still remain
FrOntrak Prices $4M public offering with warrant package
FrAllegiant sees May passenger traffic increase over 9%
FrAmplify Cash Flow High Income ETF declares $0.1892 dividend
FrRiverview Bancorp declares $0.02 dividend
FrPlanet Ventures makes first Bitcoin purchase in $500K treasury allocation move
FrAscent Solar Technologies signs supply contract with US-based defense solutions provider
FrWeyerhaeuser downwardly revises Q2 guidance for Wood Products unit
FrAlpha Pro Tech expands share buyback program by $2M
FrCyngn inc. announces $17.2 million registered direct offering
FrCVS Health PBM to pay feds $95M for overcharging Medicare drugs
FrShell hikes natural gas production at Norway's Ormen Lange field
FrBone Biologics prices $5M public offering with warrants; shares up 45%
FrHelius Medical Technologies announces reverse stock split
FrFed's Kashkari expects two 2025 rate cuts, first possibly in September
FrThe U.S. isn't seeking to 'decouple' from China but to 'de-risk', Bessent says
FrEvercore thinks Trade Desk safe from Amazon's competitive push, but Google isn't
FrBristol Myers wins favorable FDA label updates for cell therapies Breyanzi and Abecma
FrPCE in charts: Core rate ticks up in May
FrEastman board appoints new director
FrBTIG assumes coverage of Compass with Buy on recovery, growth potential
FrVNET raises full year 2025 revenue and adjusted EBITDA guidance; shares up over 5%